Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer.

Chang JY, Liu HH, Komaki R.

Curr Oncol Rep. 2005 Jul;7(4):255-9. Review.

PMID:
15946583
2.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1087-96. Epub 2006 May 6.

PMID:
16682145
3.
4.

Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.

Lievens Y, Nulens A, Gaber MA, Defraene G, De Wever W, Stroobants S, Van den Heuvel F; Leuven Lung Cancer Group.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):306-13. doi: 10.1016/j.ijrobp.2010.06.025. Epub 2010 Oct 1.

PMID:
20888706
5.

Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.

Roelofs E, Engelsman M, Rasch C, Persoon L, Qamhiyeh S, de Ruysscher D, Verhaegen F, Pijls-Johannesma M, Lambin P; ROCOCO Consortium.

J Thorac Oncol. 2012 Jan;7(1):165-76. doi: 10.1097/JTO.0b013e31823529fc.

7.

Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.

Lopez Guerra JL, Gomez DR, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e537-43. doi: 10.1016/j.ijrobp.2012.01.019. Epub 2012 Mar 13.

8.

IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.

Fleckenstein J, Kremp K, Kremp S, Palm J, Rübe C.

Strahlenther Onkol. 2016 Feb;192(2):75-82. doi: 10.1007/s00066-015-0900-9. Epub 2015 Oct 5.

PMID:
26438071
9.

An isotoxic planning comparison study for stage II-III non-small cell lung cancer: is intensity-modulated radiotherapy the answer?

Warren M, Webster G, Ryder D, Rowbottom C, Faivre-Finn C.

Clin Oncol (R Coll Radiol). 2014 Aug;26(8):461-7. doi: 10.1016/j.clon.2014.03.011. Epub 2014 May 3.

PMID:
24793504
10.

Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.

Ohno T, Oshiro Y, Mizumoto M, Numajiri H, Ishikawa H, Okumura T, Terunuma T, Sakae T, Sakurai H.

J Radiat Res. 2015 Jan;56(1):128-33. doi: 10.1093/jrr/rru082. Epub 2014 Nov 3.

11.

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Nichols RC, Huh SN, Henderson RH, Mendenhall NP, Flampouri S, Li Z, D'Agostino HJ, Cury JD, Pham DC, Hoppe BS.

Clin Lung Cancer. 2011 Jul;12(4):252-7. doi: 10.1016/j.cllc.2011.03.027. Epub 2011 Apr 27.

PMID:
21726825
12.

[Non-small-cell bronchial cancers: improvement of survival probability by conformal radiotherapy].

Giraud P, Helfre S, Lavole A, Rosenwald JC, Cosset JM.

Cancer Radiother. 2002 Nov;6 Suppl 1:125s-134s. Review. French.

PMID:
12587391
13.

The impact of three-dimensional radiation on the treatment of non-small cell lung cancer.

Armstrong J, McGibney C.

Radiother Oncol. 2000 Aug;56(2):157-67. Review.

PMID:
10927134
14.

Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study.

Lavrenkov K, Singh S, Christian JA, Partridge M, Nioutsikou E, Cook G, Bedford JL, Brada M.

Radiother Oncol. 2009 Jun;91(3):349-52. doi: 10.1016/j.radonc.2008.10.005. Epub 2008 Nov 6.

PMID:
18995919
15.

Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer.

Manon RR, Jaradat H, Patel R, Zhang T, Fenwick J, Tome W, Fowler J, Paliwal B, Soisson E, Yuan Z, Mehta M.

Clin Lung Cancer. 2005 Sep;7(2):107-13.

PMID:
16179097
16.

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1258-67. Erratum in: Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):921. Change, Joe T [corrected to Chang, Joe T].

PMID:
15001271
18.

New radiotherapy approaches in locally advanced non-small cell lung cancer.

Christodoulou M, Bayman N, McCloskey P, Rowbottom C, Faivre-Finn C.

Eur J Cancer. 2014 Feb;50(3):525-34. doi: 10.1016/j.ejca.2013.11.027. Epub 2013 Dec 12. Review.

PMID:
24333095
19.

Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges.

Ishikura S.

Gen Thorac Cardiovasc Surg. 2012 Mar;60(3):127-31. doi: 10.1007/s11748-011-0832-y. Epub 2012 Mar 15. Review.

PMID:
22419179
20.

Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Guckenberger M, Kavanagh A, Partridge M.

Strahlenther Onkol. 2012 Oct;188(10):894-900. Epub 2012 Aug 31.

PMID:
22933031

Supplemental Content

Support Center